UK Life Sciences Market Segmentation
Life Sciences By Product (USD Million, 2025-2035)
- Novel Oral Anticoagulants
- Warfarin
Life Sciences By Disease Indication (USD Million, 2025-2035)
- Atrial Fibrillation
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Heart Attacks
Life Sciences By Distribution Channel (USD Million, 2025-2035)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies